Skip to content

Immune activation marker, cheap and easy to measure, compares well with CD4 count

Is an AIDS vaccine possible? Experts more optimistic after annual vaccine meeting

AIDS vaccine: lack of planning on vectors risks future public health gains

AIDS vaccine could avert up to 27 million infections by 2030

Awareness and use of HIV pre-exposure prophylaxis (PrEP) are found to be low in San Francisco gay and bisexual men

Draft guidelines on prosecuting sexual transmission of HIV, other STIs, in England and Wales now open for public consultation

Safer crack-smoking resources as a viable addition to comprehensive harm reduction programs for reducing HIV and HCV transmission

Recombinant forms of HIV emerging rapidly, vaccine designs must keep pace

Swedish prime-boost HIV DNA vaccine shows strong responses